Filtros de búsqueda

Lista de obras de

A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity

artículo científico publicado en 2020

Advanced Ovarian Cancer Displays Functional Intratumor Heterogeneity That Correlates to Ex Vivo Drug Sensitivity

artículo científico publicado en 2016

BGCS uterine cancer guidelines: Recommendations for practice

artículo científico publicado en 2017

Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer

artículo científico publicado en 2017

Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition ⬇️

artículo científico publicado en 2015

Copy number signatures and mutational processes in ovarian carcinoma

artículo científico publicado en 2018

Correction: Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium

artículo científico publicado en 2019

DNA damage repair in ovarian cancer: unlocking the heterogeneity.

artículo científico publicado en 2018

Decision-Making in Gynaecological Oncology Multidisciplinary Team Meetings: A Cross-Sectional, Observational Study of Ovarian Cancer Cases

scientific article published on 19 November 2019

Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours

scientific article published on 15 October 2020

Epithelial ovarian cancer risk: A review of the current genetic landscape

artículo científico publicado en 2019

Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells

scientific article published on 23 July 2018

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease.

artículo científico publicado en 2016

High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers

artículo científico publicado en 2015

Hormone replacement therapy after treatment for a gynaecological malignancy

artículo científico publicado en 2015

Impact of surgical site infection (SSI) following gynaecological cancer surgery in the UK: a trainee-led multicentre audit and service evaluation

artículo científico publicado en 2019

Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UK. ⬇️

artículo científico publicado en 2016

Interventions for weight reduction in obesity to improve survival in women with endometrial cancer

artículo científico publicado en 2018

Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies

artículo científico publicado en 2016

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative

artículo científico publicado en 2017

Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib

artículo científico publicado en 2016

PROgesterone Therapy for Endometrial Cancer protection in obese women (PROTEC) trial: a feasibility study

scientific article published on 30 September 2020

Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903

artículo científico publicado en 2019

Population based testing of non-mucinous epithelial ovarian cancer in Scotland

artículo científico publicado en 2018

Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer.

artículo científico publicado en 2016

Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer

artículo científico publicado en 2017

Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters

artículo científico publicado en 2015

Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases

scientific article published on 25 January 2019

Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative

artículo científico publicado en 2018

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels

artículo científico publicado en 2020

Survival of women with early-stage cervical cancer in the UK treated with minimal access and open surgery

scientific article published on 01 March 2019

The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study

artículo científico publicado en 2017

The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis

artículo científico publicado en 2014

Values of educational visits in obstetrics. Staff changes will have affected ventouse rates

What do we do with all the false-positive CA125s? ⬇️

artículo científico publicado el 24 de mayo de 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda